Pentwater Capital Management LP Ab Cellera Biologics Inc. Transaction History

Pentwater Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$7.46 - $14.14 $1.03 Million - $1.94 Million	-137,500 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$12.99 - $17.73 $454,650 - $620,550	35,000 Added 34.15%	137,500 $1.97 Million
Q3 2021 Nov 15, 2021	SELL	$14.85 - $21.34 $148,500 - $213,400	-10,000 Reduced 8.89%	102,500 $2.05 Million
Q2 2021 Aug 16, 2021	BUY	$20.19 - $34.17 $2.27 Million - $3.84 Million	112,500 New	112,500 $2.48 Million

153

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $761M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Pentwater Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Pentwater Capital Management LP with notifications on news.